Core Scientific (CORZ) Amortization of Deferred Charges (2021 - 2025)

Core Scientific has disclosed Amortization of Deferred Charges across 4 years of filings, most recently posting $1.3 million for Q3 2025.

• Amortization of Deferred Charges for Q3 2025 came in at $1.3 million, down 53.53% year-over-year; the trailing twelve-month figure through Dec 2025 was $4.3 million (down 1.45% YoY), and the FY2024 annual result was $3.7 million, changed N/A from the prior year.
• Amortization of Deferred Charges came in at $1.3 million for Q3 2025 at Core Scientific, up from $1.3 million in the prior quarter.
• In the past five years, Amortization of Deferred Charges ranged from a high of $6.2 million in Q4 2021 to a low of -$270000.0 in Q4 2024.
• The 4-year median for Amortization of Deferred Charges is $1.3 million (2025), against an average of $1.9 million.
• Peak annual rise in Amortization of Deferred Charges reached 1353.77% in 2022, while the deepest fall reached 84.59% in 2022.
• Core Scientific's Amortization of Deferred Charges stood at $6.2 million in 2021, then sank by 84.59% to $963000.0 in 2022, then slumped by 128.04% to -$270000.0 in 2024, then jumped by 585.56% to $1.3 million in 2025.
• The last three Amortization of Deferred Charges figures came in at $1.3 million (Q3 2025), $1.3 million (Q2 2025), and $1.7 million (Q1 2025), per Business Quant data.